An Introduction to DNA Microarray Technology Is Provide In New Book Cancer Diagnostics With DNA Microarrays
Posted on: Wednesday, 13 September 2006, 12:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c41999) has announced the addition of Cancer Diagnostics with DNA Microarrays to their offering.
This book is the first of its kind in dealing with direct clinical application of microarray data to oncology diagnosis, with the intention of speeding and specifying diagnosis, thus resulting in better treatment for cancer patients. Replete with examples and mini-cases, the book offers cancer researchers in private, pharmacologic, and governmental institutions, biomedical statisticians, and practicing oncologists concise, thoughtfully authored guidance on the use of microarray data and analysis as clinical tools. Some research-level readers may find certain introductory and review somewhat superficial, but these can be skipped over if necessary, and there is much useful, detailed information provided to further the understanding of the many aspects of microarray technology that can be applied to medical diagnostics in oncology.
Contents Include:
Preface
Acknowledgments
1. Introduction to DNA Microarray Technology
2. Image Analysis
3. Basic Data Analysis
4. Visualization by Reduction of Dimensionality
5. Cluster Analysis
6. Molecular Classifiers for Cancer
7. Survival Analysis
8. Meta-Analysis
9. The Design of Probes
10. Software Issues and Data Formats
11. Breast Cancer
12. Leukaemia
13. Lymphoma
14. Lung Cancer
15. Bladder Cancer
16. Colon Cancer
17. Ovarian Cancer
18. Prostate Cancer
19. Melanoma
20. Brain Tumours
21. Organ or Tissue Specific Classification
22. Sample Collection and Stability
References
Index
For more information visit http://www.researchandmarkets.com/reports/c41999
Source: Business Wire
Related Articles
- Digital Accessibility Trends Analysis (DATA) Offers Global Disability Policy, Legal and Marketplace Drivers
- Abraxis Reports Promising Pancreatic Cancer Trial Data
- CEL-SCI Presents Long-Term Cancer Survival Data With Multikine(R)
- Active Biotech Presents Positive Cancer Drug Data
- Antisoma Encouraged By Cancer Drug Data
- Northwest Biotherapeutics Updates Brain Cancer Clinical Data
- Cancer Survival Data From Multikine to Be Presented in May 2006
- Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
- Statins Do Nothing to Fight Cancer, Analysis Finds
- Antisoma says lung cancer drug data promising
User Comments (0)

RSS Feeds